Human Neutrophil Peptide-1 to 3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Human Neutrophil Peptide-1 to 3, covering 2015-10-29 to 2015-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3